Status: current, Defined. Date: 30-Jun 2019. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3357011000168111 | Xeljanz (tofacitinib 10 mg) tablet (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 3357021000168116 | Xeljanz 10 mg tablet | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Xeljanz 10 mg tablet | Is a | tofacitinib 10 mg tablet | true | Inferred relationship | Some | ||
| Xeljanz 10 mg tablet | Is a | trade product unit of use | true | Inferred relationship | Some | ||
| Xeljanz 10 mg tablet | Is a | Xeljanz | true | Inferred relationship | Some | ||
| Xeljanz 10 mg tablet | has manufactured dose form | tablet | true | Inferred relationship | Some | ||
| Xeljanz 10 mg tablet | has unit of use | tablet | true | Inferred relationship | Some | 2023085733 | |
| Xeljanz 10 mg tablet | has Australian BoSS | tofacitinib | true | Inferred relationship | Some | 2023085732 | |
| Xeljanz 10 mg tablet | has intended active ingredient | tofacitinib | true | Inferred relationship | Some | 2023085732 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Xeljanz 10 mg tablet, 14 | has TPUU | True | Xeljanz 10 mg tablet | Inferred relationship | Some | 1 |
| Xeljanz 10 mg tablet, 56 | has TPUU | True | Xeljanz 10 mg tablet | Inferred relationship | Some | 1 |
| Xeljanz 10 mg tablet, 14, blister pack | has TPUU | True | Xeljanz 10 mg tablet | Inferred relationship | Some | 1 |
| Xeljanz 10 mg tablet, 56, blister pack | has TPUU | True | Xeljanz 10 mg tablet | Inferred relationship | Some | 1 |
Reference Sets
Black Triangle Scheme reference set
Trade product unit of use reference set
FHIR